London-based private equity firm BC Partners has acquired a majority stake in French natural healthcare group Havea from 3i Group in a deal worth €1.6 billion.
BC Partners transacted the deal in partnership with PSP Investments and National Pensions Services Investment Management (NPS).
The deal represent around 50% uplift for 3i on its 31 March valuation.
Havea owns brands including Aragan, Biolane and Vitavea, employs over 800 people and is headquartered in Boufféré, France.
The transaction which remains subject to regulatory and antitrust approvals, is expected to close by Q4 2022.
